This topic contains a solution. Click here to go to the answer

Author Question: Which one of the following is not a strength of the mixed method approach? a. A researcher does ... (Read 109 times)

erika

  • Hero Member
  • *****
  • Posts: 522
Which one of the following is not a strength of the mixed method approach?
 
  a. A researcher does not have to conform to just a single methodology.
  b. It can generate insights missed by the other method not chosen.
  d.
  It can potentially provide a more complete understanding of a very complicated phenomenon.
  d.
  It is a method that will have more scientific credibility and value.

Question 2

One effective criterion that can be used to judge the rigor (quality) of the mixed methods approach is to determine
 
  a. whether the design can generate the best possible answers to the posted research questions to be pursued.
  b. whether the design can provide consistency in interpretation of the data throughout the study.
  c. Neither of these.
  d. a and b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

pangili4

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

D

Answer to Question 2

D




erika

  • Member
  • Posts: 522
Reply 2 on: Jun 20, 2018
Great answer, keep it coming :)


steff9894

  • Member
  • Posts: 337
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

For a complete list of videos, visit our video library